QOP
BNTX icon

Quinn Opportunity Partners’s BioNTech BNTX Stock Holding History

Quinn Opportunity Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,000
Closed -$4.15M – 285
2024
Q1 		$4.15M Hold
45,000
– – 0.46% 57
2023
Q4 		$4.75M Hold
45,000
– – 0.49% 55
2023
Q3 		$4.89M Hold
45,000
– – 0.63% 43
2023
Q2 		$4.86M Buy
+45,000
New +$5.06M 0.66% 41

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quinn Opportunity Partners's BNTX Position: Q1 2026 in Review

Quinn Opportunity Partners increased its BioNTech (BNTX) stake by 305% in Q1 2026, buying an estimated $17.7M and bringing the position to 228,832 shares worth $20.3M. The position accounts for 1.06% of the portfolio, ranked #20.

Quinn Opportunity Partners first reported a position in BNTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $71.6M in Q3 2023. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Quinn Opportunity Partners held 228,832 shares of BioNTech worth $20.3M as of Q1 2026.
  • Quinn Opportunity Partners bought 172,332 BioNTech shares in Q1 2026, an estimated $17.7M.
  • BioNTech made up 1.06% of Quinn Opportunity Partners's portfolio in Q1 2026, its #20 holding.
  • Quinn Opportunity Partners first reported a position in BioNTech in Q4 2020 and has held it in 22 quarters since.
  • Quinn Opportunity Partners's BioNTech position peaked at $71.6M in Q3 2023.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.